Sign in
Taking people in South KoreaNo phase

Studying gut bacteria in people with inflammatory bowel disease

Observes gut bacteria and related features in Korean patients with inflammatory bowel disease.

Key facts

Who runs it
Kyunghee University Medical Center
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Gut Microbiome in Inflammatory Bowel Disease
Status
Recruiting
People taking part
1,500 people, planned
Started
1 Apr 2018
Expected to end
31 Mar 2028
Type of study
Observational
Record updated
10 March 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with an established diagnosis of inflammatory bowel disease, either ulcerative colitis or Crohn disease.

Sex
Women and men can join.
Disease stage
An established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease.
Earlier treatment
People who used antibiotics or probiotics within the previous 2 weeks cannot join.

Main reasons for not taking part

  • Used antibiotics within the previous 2 weeks
  • Used probiotics within the previous 2 weeks

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease

Who cannot take part

  • Person with history of using antibiotics or probiotics within previous 2 weeks

Where in South Korea

  • Kyung Hee University HospitalSeoul, South KoreaContact: Chang Kyun Lee, MD, PhDTaking people

About the trial

What the trial wants to find out

Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity.

Read full original descriptionShow less

In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Discovery of Gut Microbial Signatures in Inflammatory Bowel Disease
Plain-language title
Studying gut bacteria in people with inflammatory bowel diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
10 March 2023